Development of new antituberculous agents based on new drug targets and structure-activity relationship (Q40138610)

17 September 2017

title

Development of new antituberculous agents based on new drug targets and structure-activity relationship (English)

1 reference

17 September 2017

Haruaki Tomioka

1

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Drug Discovery

17 September 2017

published in

1 reference

17 September 2017

volume

3

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

21-49

1 reference

TB drug discovery: addressing issues of persistence and resistance

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Fluoroquinolones, tuberculosis, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

New small-molecule synthetic antimycobacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antituberculosis drugs: ten years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Diarylquinolines target subunit c of mycobacterial ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activities of oxazolidinones: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Linezolid for the treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification and validation of novel drug targets in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structural bioinformatic approaches to the discovery of new antimycobacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The magic bullets and tuberculosis drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Novel targets for tuberculosis drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Ppm1, a novel polyprenol monophosphomannose synthase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The pimB gene of Mycobacterium tuberculosis encodes a mannosyltransferase involved in lipoarabinomannan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

PimF, a mannosyltransferase of mycobacteria, is involved in the biosynthesis of phosphatidylinositol mannosides and lipoarabinomannan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of PapA5, a phthiocerol dimycocerosyl transferase from Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

rmlB and rmlC genes are essential for growth of mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis RmlC epimerase (Rv3465): a promising drug-target structure in the rhamnose pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

IdeR in mycobacteria: from target recognition to physiological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structures, metal activation, and DNA-binding properties of two-domain IdeR from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Overexpression, purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of 2-methyl-adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Metabolism of 2-methyladenosine in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Dynamic QSAR techniques: applications in drug design and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Electronic-topological study of structurally diverse cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The structure--antituberculosis activity relationships study in a series of 5-(4-aminophenyl)-4-substituted-2,4-dihydro-3h-1,2,4-triazole-3-thione derivatives. A combined electronic-topological and neural networks approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Rationalization of physicochemical characters of oxazolyl thiosemicarbazone analogs towards multi-drug resistant tuberculosis: a QSAR approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

BM 212 and its derivatives as a new class of antimycobacterial active agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

N-[4-(1,1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antituberculosis activity of certain antifungal and antihelmintic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of new ortho-, meta- and para-toluidine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activities of riminophenazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A new class of antituberculosis agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of 9-sulfonylated/sulfenylated-6-mercaptopurine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro antimycobacterial activities of 2'-monosubstituted isonicotinohydrazides and their cyanoborane adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Chloropyrimidines as a new class of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of 5-arylidene derivatives of hydantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Peptide deformylase inhibitors as potent antimycobacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antituberculous activity of some aryl semicarbazone derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of synthetic pamamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl alpha-(5-aryl-1, 3, 4-thiadiazole-2-ylthio)acetates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of Mycobacterium tuberculosis diaminopimelate decarboxylase, an essential enzyme in bacterial lysine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of LysA (Rv1293) from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Purification and characterization of a functionally active Mycobacterium tuberculosis pyrroline-5-carboxylate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The crystal structure of TrpD, a metabolic enzyme essential for lung colonization by Mycobacterium tuberculosis, in complex with its substrate phosphoribosylpyrophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystallization and preliminary X-ray crystallographic analysis of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Expression, purification and properties of shikimate dehydrogenase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Functional shikimate dehydrogenase from Mycobacterium tuberculosis H37Rv: purification and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Functional characterization of a novel ArgA from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Acetohydroxyacid synthase from Mycobacterium avium and its inhibition by sulfonylureas and imidazolinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Branched-chain amino acid aminotransferase and methionine formation in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Invariance and variability in bacterial PanK: a study based on the crystal structure of Mycobacterium tuberculosis PanK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Expression, purification, crystallization and preliminary X-ray crystallographic analysis of pantothenate kinase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of Mycobacterium tuberculosis MenB, a key enzyme in vitamin K2 biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure of naphthoate synthase (MenB) from Mycobacterium tuberculosis in both native and product-bound forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

5'-adenosinephosphosulfate lies at a metabolic branch point in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A conserved mechanism for sulfonucleotide reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Noncovalent complexes of APS reductase from M. tuberculosis: delineating a mechanistic model using ESI-FTICR MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycothiol Is Essential for Growth ofMycobacterium tuberculosisErdman

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A coupled spectrophotometric assay for l-cysteine:1-D-myo-inosityl 2-amino-2-deoxy-alpha-D-glucopyranoside ligase and its application for inhibitor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) is a key enzyme in mycothiol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Purification and characterization of Mycobacterium tuberculosis 1D-myo-inosityl-2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase, MshB, a mycothiol biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The crystal structure of 1-D-myo-inosityl 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) from Mycobacterium tuberculosis reveals a zinc hydrolase with a lactate dehydrogenase fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of mycothiol synthase (Rv0819) fromMycobacterium tuberculosisshows structural homology to the GNAT family of N-acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Ribonucleotide Reduction in Mycobacterium tuberculosis : Function and Expression of Genes Encoding Class Ib and Class II Ribonucleotide Reductases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Biochemical and genetic analysis of the four DNA ligases of mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification and Characterization of a Unique Adenosine Kinase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The carboxy-terminal end of the peptide deformylase from Mycobacterium tuberculosis is indispensable for its enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Oligosaccharides as inhibitors of mycobacterial arabinosyltransferases. Di- and trisaccharides containing C-3 modified arabinofuranosyl residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Expression, purification, and characterization of a galactofuranosyltransferase involved in Mycobacterium tuberculosis arabinogalactan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Cell wall core galactofuran synthesis is essential for growth of mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

UDP-galactopyranose mutase has a novel structure and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Molecular genetic analysis of enoyl-acyl carrier protein reductase inhibition by diazaborine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of new inhibitors of E. coli cyclopropane fatty acid synthase using a colorimetric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Inactivation of the polyketide synthase, 6-methylsalicylic acid synthase, by the specific modification of Cys-204 of the beta-ketoacyl synthase by the fungal mycotoxin cerulenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase co

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystallization and preliminary crystallographic analysis of PimA, an essential mannosyltransferase from Mycobacterium smegmatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Interaction between polyketide synthase and transporter suggests coupled synthesis and export of virulence lipid in M. tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

glnE is an essential gene in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The role of GlnD in ammonia assimilation in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

An essential two-component signal transduction system in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Modulation of Mycobacterium tuberculosis proliferation by MtrA, an essential two-component response regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Functional studies of the Mycobacterium tuberculosis iron-dependent regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Mycobacterium bovis BCG response regulator essential for hypoxic dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The relA homolog of Mycobacterium smegmatis affects cell appearance, viability, and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Molecular dissection of the mycobacterial stringent response protein Rel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

The mechanism of Mycobacterium tuberculosis alkylhydroperoxidase AhpD as defined by mutagenesis, crystallography, and kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Crystal structure and functional analysis of lipoamide dehydrogenase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Novel prenyl-linked benzophenone substrate analogues of mycobacterial mannosyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

Identification of a Novel Arabinofuranosyltransferase AftB Involved in a Terminal Step of Cell Wall Arabinan Biosynthesis in Corynebacterianeae, such asCorynebacterium glutamicumandMycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.3.1.21

21 January 2018

Identifiers

DOI

10.1517/17460441.3.1.21

1 reference

17 September 2017

1 reference